NSRX Nasus Pharma Ltd.
Company Analysis
Latest News
🔴 Nasus Pharma is trading 6.25% down with no confirmed catalyst
Nasus Pharma is trading at $3.00, down 6.25%, with no confirmed catalyst for the November 4 decline. - No company-specific announcement explaining the...
🟢 Nasus Pharma is trading 6% up today with no confirmed catalyst
Nasus Pharma is trading 6.12% higher at $3.40 on November 3, 2026, with no specific announcement found to explain the rise. - Available company-news listings...
🔴 Nasus Pharma is trading 5% down in pre-market with no confirmed catalyst
Nasus Pharma is trading 5.29% lower at $3.03, with no confirmed company announcement explaining the pre-market decline. - The November 2 close was $3.20; a...
🟢 Nasus Pharma is trading 5% up today amid a broad market rebound
Nasus Pharma is trading at $3.23, up +5.05%, amid a broad market rebound. - The S&P 500, Nasdaq, and Dow were each up more than 0.5%; improving sentiment...
🔴 Nasus Pharma is trading 5.9% down with no clear catalyst identified
Nasus Pharma is trading 5.9% lower at $3.28 on October 27, 2026, with no clear catalyst identified. - No company-specific announcement explaining the decline...
🟢 Nasus Pharma is trading 8.5% up with no company-specific catalyst identified
Nasus Pharma is trading 8.5% higher at $3.50 on October 23, 2026, with no company-specific announcement identified for the move. - The prior session closed at...
🟢 Nasus Pharma is trading 17% up today with healthcare shares offering possible support
Nasus Pharma is trading at $3.58, up 16.99% in live trading on October 22, 2026, with healthcare-sector strength a possible support. - No new company-specific...
🟢 Nasus Pharma is trading 8.17% up today with no identified company-specific catalyst
Nasus Pharma is trading at $3.31, up 8.17%, with no identified company-specific announcement explaining its October 22, 2026 move. - The latest company news...
🔴 Nasus Pharma is trading 10% down in after-hours trading; catalyst remains unclear
Nasus Pharma is trading at $3.00, down 10.04% after hours; the catalyst for the October 21 decline remains unclear. - No company-specific announcement...
🔴 Nasus Pharma is trading 8.25% down in after-hours trading — catalyst remains uncertain
Nasus Pharma is trading at $3.06 (-8.25%) as the cause of its October 21 after-hours decline remains uncertain. - No new company-specific announcement...
🟢 Nasus Pharma is trading 10.8% up on October 21, 2026 — no specific cause identified
Nasus Pharma is trading at $3.59, up 10.80%, with no specific cause identified for its October 21 move. - No new company-specific catalyst explaining the move...
🔴 Nasus Pharma is trading 5.9% down in pre-market with no company-specific catalyst identified
Nasus Pharma is trading at $3.05, down 5.86% in pre-market, with no company-specific catalyst identified. - No new company-specific announcement explaining...
🟢 Nasus Pharma is trading 6.3% up today amid broader-market gains
Nasus Pharma is trading up 6.29% at $3.38 on October 19, 2026, amid broader-market strength; no company-specific catalyst has been verified. - The S&P 500 was...
🔴 Nasus Pharma is trading 5.3% down in after-hours trading with no clear company-specific catalyst
Nasus Pharma is trading 5.3% down at $3.10 after the October 13 regular-session close at $3.27; no clear company-specific catalyst has been identified for the...
🔴 Nasus Pharma is trading 5% down today amid healthcare-sector weakness
Nasus Pharma is trading 5.12% down at $3.15, with no clear company-specific catalyst identified for October 13, 2026. - The healthcare sector is down 1.37%,...
🔴 Nasus Pharma is trading 6% down on October 12, 2026
Nasus Pharma is trading 5.98% down at $3.30, with no clear company-specific catalyst identified for October 12, 2026. - The latest located company...
🟢 Nasus Pharma is trading 5.8% up in after-hours trading with no identified company-specific catalyst
Nasus Pharma is trading 5.8% higher in after-hours trading at $3.65, versus its October 9 regular-session close of $3.51; no clear company-specific...
🔴 Nasus Pharma is trading 7.3% down on October 8, 2026 as inflation fears pressure stocks
Nasus Pharma is trading at $3.50, down 7.28%, during the October 8 session amid broad risk-off pressure, as higher oil prices and Treasury yields stoked...
🟢 Nasus Pharma is trading 7% up today alongside broader market gains
Nasus Pharma is trading at $4.09, up +7.21%, alongside a broader risk-on session; no company-specific cause has been established. - Major U.S. indexes are...
🟢 Nasus Pharma is trading 8.6% up today after first patient dosed in NS003 Phase 1
Nasus Pharma is trading 8.6% higher at $4.01 after the first patient was enrolled and dosed in its NS003 Phase 1 study. - The September 29 announcement...